{
  "id": 16652,
  "label": "vitamin K-antagonist embryofetopathy",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0016010",
  "properties": {
    "xrefs": [
      "ICD9:759.89",
      "MEDGEN:75570",
      "MESH:C536683",
      "MedDRA:10051445",
      "NCIT:C98906",
      "Orphanet:1914",
      "SCTID:38323006",
      "UMLS:C0265374",
      "icd11.foundation:71579696"
    ],
    "synonyms": [
      "di Sala syndrome",
      "fetal Coumadin syndrome",
      "fetal warfarin syndrome",
      "foetal Coumadin syndrome",
      "foetal warfarin syndrome",
      "vitamin K antagonist embryopathy",
      "vitamin K-antagonist embryofetopathy",
      "vitamin K-antagonist embryopathy",
      "warfarin embryofetopathy",
      "warfarin embryopathy",
      "DiSala syndrome",
      "congenital warfarin syndrome",
      "coumarin embryopathy",
      "coumarin syndrome",
      "embryofetopathy due to oral anticoagulant therapy",
      "fetal anticoagulant syndrome",
      "foetal anticoagulant syndrome",
      "vitamin K antagonist embryofetopathy",
      "vitamin K antagonists embryofetopathy",
      "warfarin syndrome"
    ],
    "categories": [
      {
        "ref": "MONDO:0002254",
        "name": "syndromic disease"
      }
    ],
    "definition": "A teratogenic disorder observed in a newborn or child of a mother who was exposed to warfarin during pregnancy. Manifestations include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly."
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 4370,
      "label": "syndromic disease",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        29379
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "DOID:225",
          "MEDGEN:11688",
          "MESH:D013577",
          "NCIT:C28193",
          "OGMS:0000086",
          "UMLS:C0039082"
        ],
        "synonyms": [
          "cluster, symptom",
          "clusters, symptom",
          "symptom cluster",
          "symptom clusters",
          "syndrome",
          "syndrome associated with disease or disorder",
          "syndromes",
          "syndromic disease",
          "syndromic disease or disorder"
        ],
        "categories": [
          {
            "ref": "MONDO:0002254",
            "name": "syndromic disease"
          }
        ],
        "definition": "A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition."
      },
      "child_count": 1182,
      "reference_id": "MONDO:0002254"
    },
    {
      "id": 17143,
      "label": "toxic or drug-related embryofetopathy",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        19507
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "MEDGEN:1843068",
          "MESH:D000014",
          "Orphanet:251529",
          "UMLS:C5680710",
          "icd11.foundation:293076727"
        ],
        "definition": "Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment."
      },
      "child_count": 22,
      "reference_id": "MONDO:0016677"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 4370,
      "label": "syndromic disease"
    },
    {
      "id": 17143,
      "label": "toxic or drug-related embryofetopathy"
    }
  ]
}